Physician profile
Claudio E Linares
NPI 1831194646
$2,540.20
in general payments reported to CMS, 2019-2025
20 companies · $16.15 in 2025
The $16.15 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $581 · 2020: $244 · 2021: $152 · 2022: $1,217 · 2023: $330 · 2025: $16.15.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $256 · Education: $90.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $256.25 |
| Education | $90.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Momentis Surgical INC. | $1,003.00 | 2022 | |
| Abbvie INC. | $589.58 | 2019-2023 | |
| Coopersurgical, INC. | $294.26 | 2019-2023 | Summit Doppler |
| Astellas Pharma US INC | $104.50 | 2023 | Veozah |
| Mylan Pharmaceuticals INC. | $82.40 | 2019-2022 | |
| Pfizer INC. | $68.47 | 2019-2023 | |
| Avion Pharmaceuticals | $54.55 | 2021-2022 | |
| Heron Therapeutics, INC. | $45.63 | 2023 | Zynrelef |
| Myovant Sciences INC. | $45.34 | 2021-2022 | |
| Daiichi Sankyo INC. | $41.76 | 2019 | |
| Exeltis, USA INC. | $34.06 | 2021-2023 | Slynd |
| Therapeuticsmd, INC. | $32.15 | 2022 | |
| Gynesonics, INC. | $24.69 | 2023 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Pacira Pharmaceuticals Incorporated | $23.90 | 2023 | Exparel |
| Sumitomo Pharma America, INC. | $22.24 | 2023 | Myfembree |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $16.74 | 2019 | |
| Aspira Women'S Health INC | $16.36 | 2019 | |
| Millicent US INC | $16.15 | 2025 | Femlyv |
| Scynexis, INC. | $13.09 | 2022 | |
| Lupin INC. | $11.33 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Claudio Linares listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.